ClinicalTrials.govpublic full text
Immune Neoadjuvant Therapy Study of Durvalumab in Early Stage Non-small Cell Lung Cancer
carcinoma, non-small-cell lung, ifct, neodjuvant, immune therapy, non small cell lung cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828003
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.